样式: 排序: IF: - GO 导出 标记为已读
-
Contraception, Intrauterine Systems, and Depression: Can We Spot the Real Perpetrator? Am. J. Psychiatry (IF 15.1) Pub Date : 2024-09-01 Claudio N Soares
-
Positioning rTMS Within a Sequential Treatment Algorithm of Depression. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-09-01 Tyler S Kaster,Daniel M Blumberger
-
Genetic Underpinnings of Peer Influence in Adolescents. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-09-01 Sara R Jaffee
-
"Closing the Loop" With Transcranial Electrical Stimulation for Depression. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-09-01 Donel M Martin,Stevan Nikolin
-
Depression: Factors Contributing to Risk and Therapeutic Insights. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-09-01 Ned H Kalin
-
Ketamine, the First Associative Anesthetic? Some Considerations on Classifying Psychedelics, Entactogens, and Dissociatives. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-09-01 Nicholas Denomme,Boris D Heifets
-
Resting-State Functional Connectivity of the Amygdala in Autism: A Preregistered Large-Scale Study. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-29 Dorit Kliemann,Paola Galdi,Avery L Van De Water,Brandon Egger,Dorota Jarecka,Ralph Adolphs,Satrajit S Ghosh
OBJECTIVE Three leading neurobiological hypotheses about autism spectrum disorder (ASD) propose underconnectivity between brain regions, atypical function of the amygdala, and generally higher variability between individuals with ASD than between neurotypical individuals. Past work has often failed to generalize, because of small sample sizes, unquantified data quality, and analytic flexibility. This
-
Peer Social Genetic Effects and the Etiology of Substance Use Disorders, Major Depression, and Anxiety Disorder in a Swedish National Sample. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-07 Jessica E Salvatore,Henrik Ohlsson,Jan Sundquist,Kristina Sundquist,Kenneth S Kendler
OBJECTIVE There is growing interest in how peers' genotypes may influence health (i.e., peer social genetic effects). The authors sought to clarify the nature of peer social genetic effects on risk for drug use disorder, alcohol use disorder (AUD), major depression, and anxiety disorder. METHOD Cox models were used with data from a population-based Swedish cohort (N=655,327). Outcomes were drug use
-
rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-07 Iris Dalhuisen,Iris van Oostrom,Jan Spijker,Ben Wijnen,Eric van Exel,Hans van Mierlo,Dieuwertje de Waardt,Martijn Arns,Indira Tendolkar,Philip van Eijndhoven
OBJECTIVE Although repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for depression, little is known about the comparative effectiveness of rTMS and other treatment options, such as antidepressants. In this multicenter randomized controlled trial, rTMS was compared with the next pharmacological treatment step in patients with treatment-resistant depression. METHODS Patients
-
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder: An Open-Label Pilot Study. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-07 Tobias Schwippel,Francesca Pupillo,Zachary Feldman,Christopher Walker,Leah Townsend,David Rubinow,Flavio Frohlich
-
Sexual Identity Continuity and Change in a U.S. National Probability Sample of Sexual Minority Adults: Associations With Mental Health and Problematic Substance Use. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Evan A Krueger,Meg D Bishop,Allen B Mallory,Ankur Srivastava,Stephen T Russell
OBJECTIVE Sexual minority disparities in behavioral health (e.g., mental health and substance use) are well-established. However, sexual identity is dynamic, and changes are common across the life course (e.g., identifying with a monosexual [lesbian or gay] label and later with a plurisexual [queer, pansexual, etc.] label). This study assessed whether behavioral health risks coincide with sexual identity
-
Neurobiology and Treatment of Posttraumatic Stress Disorder. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Arieh Shalev,Dayeon Cho,Charles R Marmar
The recent worldwide surge of warfare and hostilities exposes increasingly large numbers of individuals to traumatic events, placing them at risk of developing posttraumatic stress disorder (PTSD) and challenging both clinicians and service delivery systems. This overview summarizes and updates the core knowledge of the genetic, molecular, and neural circuit features of the neurobiology of PTSD and
-
The Invisible Children: Is the Glass Half Full or Half Empty? Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Anne A E Thorup
-
Decoding Sex Differences in PTSD Heritability: A Comprehensive Twin Study. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Seyma Katrinli,Vasiliki Michopoulos
-
More Than Social Stigma Meets the Eye: The Inherent Struggle of Sexual and Gender Identity Development Across the Lifespan. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Walter O Bockting
-
Suicide in Black Females: Response to Mattes. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Victoria A Joseph
-
PTSD, Phobias, Suicide Attempts, and Psychiatric Vulnerabilities. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Ned H Kalin
-
Neuroanatomical Subtyping of Phobias: Implications for Function and Development. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Peter A Kirk,Oliver J Robinson
-
Keeping Track and Providing Tools for Future Crisis Management: Suicide Attempt and Self-Harm Presentations at Emergency Departments. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Annette Erlangsen,Trine Madsen,Merete Nordentoft
-
Psychiatric Diagnoses in Parents and Psychiatric, Behavioral, and Psychosocial Outcomes in Their Offspring: A Swedish Population-Based Register Study. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-08-01 Mengping Zhou,Christine Takami Lageborn,Arvid Sjölander,Henrik Larsson,Brian D'Onofrio,Mikael Landén,Paul Lichtenstein,Erik Pettersson
OBJECTIVE Associations were examined between six psychiatric diagnoses in parents and a broad range of psychiatric and nonpsychiatric outcomes in their offspring. METHODS All individuals born in Sweden between 1970 and 2000 were linked to their biological parents (N=3,286,293) through Swedish national registers. A matched cohort design, with stratified Cox regression and conditional logistic regression
-
Association Between Intrauterine System Hormone Dosage and Depression Risk. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-10 Søren Vinther Larsen,Anders Pretzmann Mikkelsen,Brice Ozenne,Trine Munk-Olsen,Øjvind Lidegaard,Vibe Gedso Frokjaer
OBJECTIVE The authors compared the associated risk of incident depression between first-time users of low-, medium-, and high-dose levonorgestrel-releasing intrauterine systems (LNG-IUSs). METHODS This national cohort study was based on Danish register data on first-time users of LNG-IUSs, 15-44 years of age, between 2000 and 2022. Cox regression and a G-formula estimator were used to report 1-year
-
Entactogen Effects of Ketamine: A Reverse-Translational Study. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-10 Evan M Hess,Dede K Greenstein,Olivia L Hutchinson,Carlos A Zarate,Todd D Gould
OBJECTIVE The authors sought to assess the prosocial, entactogen effects of ketamine. METHODS Pleasure from social situations was assessed in a sample of participants with treatment-resistant depression from randomized, double-blind, placebo-controlled studies, using four items of the Snaith-Hamilton Pleasure Scale (SHAPS) at five time points over 1 week following treatment with ketamine (0.5 mg/kg
-
A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Christopher Rohde, Søren Dinesen Østergaard, Oskar Hougaard Jefsen
Objective: Antidepressants are commonly used to treat bipolar depression but may increase the risk of mania. The evidence from randomized controlled trials, however, is limited by short treatment durations, providing little evidence for the long-term risk of antidepressant-induced mania. The authors performed a target trial emulation to compare the risk of mania among individuals with bipolar depression
-
Integrating Polygenic Scores and Phenotypic Data to Understand Psychiatric Outcomes. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Katie Scott,Martin Alda
-
Affective Disorders, Pharmacogenomics, and Psychiatric Illness-Related Cardiometabolic Problems. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Ned H Kalin
-
Antidepressants and Bipolar Disorder: The Plot Thickens. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Natalie Gottlieb,Allan H Young
-
The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Jeffrey A Mattes
-
Using Medical Records to Investigate the Genetics of Treatment-Resistant Depression Across Health Care Systems. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Renato Polimanti
-
Why Psychological Problems Presage Cardiometabolic Health Problems. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Benjamin B Lahey
-
The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment: Response to Mattes. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Hemen Najar,Erik Pålsson,Mikael Landén
-
Mapping the Depressed Brain Under Stress Using Multimodal Neuroimaging. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-07-01 Teddy J Akiki,Chadi G Abdallah
-
Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-11 Kevin Hilbert, Ole Jonas Boeken, Till Langhammer, Nynke A. Groenewold, Janna Marie Bas-Hoogendam, Moji Aghajani, André Zugman, Fredrik Åhs, Volker Arolt, Katja Beesdo-Baum, Johannes Björkstrand, Jennifer U. Blackford, Laura Blanco-Hinojo, Joscha Böhnlein, Robin Bülow, Marta Cano, Narcis Cardoner, Xavier Caseras, Udo Dannlowski, Katharina Domschke, Lydia Fehm, Brandee Feola, Mats Fredrikson, Liesbet
Objective: Specific phobia is a common anxiety disorder, but the literature on associated brain structure alterations exhibits substantial gaps. The ENIGMA Anxiety Working Group examined brain structure differences between individuals with specific phobias and healthy control subjects as well as between the animal and blood-injection-injury (BII) subtypes of specific phobia. Additionally, the authors
-
Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-11 Lina Jonsson, Elin Hörbeck, Amedeo Primerano, Jie Song, Robert Karlsson, Erik Smedler, Katherine Gordon-Smith, Lisa Jones, Nicholas Craddock, Ian Jones, Patrick F. Sullivan, Erik Pålsson, Arianna Di Florio, Timea Sparding, Mikael Landén
Objective: Many but not all persons with bipolar disorder require hospital care because of severe mood episodes. Likewise, some but not all patients experience long-term occupational dysfunction that extends beyond acute mood episodes. It is not known whether these dissimilar outcomes of bipolar disorder are driven by different polygenic profiles. Here, polygenic scores (PGSs) for major psychiatric
-
Testing Quantitative and Qualitative Sex Effects in a National Swedish Twin-Sibling Study of Posttraumatic Stress Disorder Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-04 Ananda B. Amstadter, Sara L. Lönn, Shannon Cusack, Jan Sundquist, Kenneth S. Kendler, Kristina Sundquist
Objective: Twin studies have demonstrated that posttraumatic stress disorder (PTSD) is moderately heritable, and the pattern of findings across studies suggests higher heritability in females compared with males. Formal testing of sex differences has yet to be done in twin studies of PTSD. The authors sought to estimate the genetic and environmental contributions to PTSD, and to formally test for sex
-
National Trends in Emergency Department Visits for Suicide Attempts and Intentional Self-Harm Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-04 Tanner J. Bommersbach, Mark Olfson, Taeho Greg Rhee
Objective: This study estimated national annual trends and characteristics of emergency department visits for suicide attempts and intentional self-harm in the United States from 2011 to 2020. Methods: Data were from the National Hospital Ambulatory Medical Care Survey, an annual cross-sectional national sample survey of emergency departments. Visits for suicide attempts and intentional self-harm were
-
The Genesis of Schizophrenia: An Origin Story Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-01 Rebecca Birnbaum, Daniel R. Weinberger
Schizophrenia is routinely referred to as a neurodevelopmental disorder, but the role of brain development in a disorder typically diagnosed during early adult life is enigmatic. The authors revisit the neurodevelopmental model of schizophrenia with genomic insights from the most recent schizophrenia clinical genetic association studies, transcriptomic and epigenomic analyses from human postmortem
-
Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-01 Matthew M Kurtz
-
-
Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia? Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-01 Luke J Vano,Mattia Veronese,Robert A McCutcheon,Oliver D Howes
-
Advances in Understanding Schizophrenia, ADHD, and ASD. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-01 Ned H Kalin
-
Aligning Stem Cell Models and Postmortem Studies to Query Striatal Neurodevelopment in Schizophrenia. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-06-01 Kristen J Brennand
-
Long-Term Course of Remission and Recovery in Psychotic Disorders Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-15 Sara Tramazzo, Wenxuan Lian, Olesya Ajnakina, Gabrielle Carlson, Evelyn Bromet, Roman Kotov, Katherine Jonas
Objective: Understanding prognosis is critical to anticipating public health needs and providing care to individuals with psychotic disorders. However, the long-term course of remission and recovery remains unclear. In this study, the most common trajectories of illness course are described for a cohort of individuals followed for 25 years since first admission for psychosis. Methods: Participants
-
Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-15 JooEun Kang, Victor M. Castro, Michael Ripperger, Sanan Venkatesh, David Burstein, Richard Karlsson Linnér, Daniel B. Rocha, Yirui Hu, Drew Wilimitis, Theodore Morley, Lide Han, Rachel Youngjung Kim, Yen-Chen Anne Feng, Tian Ge, Stephan Heckers, Georgios Voloudakis, Christopher Chabris, Panos Roussos, Thomas H McCoy, Colin G. Walsh, Roy H. Perlis, Douglas M. Ruderfer
Objective: Treatment-resistant depression (TRD) occurs in roughly one-third of all individuals with major depressive disorder (MDD). Although research has suggested a significant common variant genetic component of liability to TRD, with heritability estimated at 8% when compared with non-treatment-resistant MDD, no replicated genetic loci have been identified, and the genetic architecture of TRD remains
-
Associations Between a Primary Care-Delivered Alcohol-Related Brief Intervention and Subsequent Opioid-Related Outcomes Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 Dan V. Blalock, Sophia A. Berlin, Theodore Berkowitz, Valerie A. Smith, Charles Wright, Rachel L. Bachrach, Janet M. Grubber
Objective: The co-occurrence of unhealthy alcohol use and opioid misuse is high and associated with increased rates of overdose, emergency health care utilization, and death. The current study examined whether receipt of an alcohol-related brief intervention is associated with reduced risk of negative downstream opioid-related outcomes. Methods: This retrospective cohort study included all VISN-6 Veterans
-
Predictors of Substance Use Initiation by Early Adolescence Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 ReJoyce Green, Bethany J. Wolf, Andrew Chen, Anna E. Kirkland, Pamela L. Ferguson, Brittney D. Browning, Brittany E. Bryant, Rachel L. Tomko, Kevin M. Gray, Louise Mewton, Lindsay M. Squeglia
Objective: Substance use initiation during early adolescence is associated with later development of substance use and mental health disorders. This study used various domains to predict substance use initiation, defined as trying any nonprescribed substance (e.g., alcohol, tobacco, cannabis), by age 12, using a large longitudinal data set. Methods: Substance-naive youths from the Adolescent Brain
-
Neural Correlates of Stress and Alcohol Cue-Induced Alcohol Craving and of Future Heavy Drinking: Evidence of Sex Differences Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 Milena Radoman, Nia Fogelman, Cheryl Lacadie, Dongju Seo, Rajita Sinha
Objective: Stress and alcohol cue reactivity are associated with poor treatment outcomes in alcohol use disorder (AUD), but sex-specific neural correlates of stress and alcohol cue–induced craving compared with neutral cue–induced craving and of heavy drinking outcomes in AUD have not been examined. Thus, this study prospectively examined these associations and assessed sex differences. Methods: Treatment-seeking
-
Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 Kirsten C. Morley, Henry R. Kranzler, Natasha Luquin, Nazila Jamshidi, Claire Adams, Mark Montebello, Chris Tremonti, Gezelle Dali, Warren Logge, Andrew Baillie, Maree Teesson, Ronald Trent, Paul S. Haber
Objective: There have been no well-controlled and well-powered comparative trials of topiramate with other pharmacotherapies for alcohol use disorder (AUD), such as naltrexone. Moreover, the literature is mixed on the effects of two polymorphisms—rs2832407 (in GRIK1) and rs1799971 (in OPRM1)—on response to topiramate and naltrexone, respectively. The authors sought to examine the comparative effectiveness
-
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 Joao P. De Aquino, Matthew E. Sloan, Julio C. Nunes, Gabriel P. A. Costa, Jasmin L. Katz, Debora de Oliveira, Jocelyn Ra, Victor M. Tang, Ismene L. Petrakis
Alcohol use disorder (AUD) and chronic pain disorders are pervasive, multifaceted medical conditions that often co-occur. However, their comorbidity is often overlooked, despite its prevalence and clinical relevance. Individuals with AUD are more likely to experience chronic pain than the general population. Conversely, individuals with chronic pain commonly alleviate their pain with alcohol, which
-
Understanding and Addressing Widening Racial Inequalities in Drug Overdose Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 Joseph R. Friedman, Max Jordan Nguemeni Tiako, Helena Hansen
The fourth wave of the United States overdose crisis—driven by the polysubstance use of fentanyl with stimulants and other synthetic substances—has driven sharply escalating racial/ethnic inequalities in drug overdose death rates. Here the authors present a detailed portrait of the latest overdose trends and synthesize the literature to describe where, how, and why these inequalities are worsening
-
Harm Reduction for Opioid Use Disorder: Strategies and Outcome Metrics Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 Jennifer D. Ellis, Kelly E. Dunn, Andrew S. Huhn
Opioid overdose deaths and opioid-related harms have reached unprecedented levels, particularly as compounds such as xylazine and fentanyl have infiltrated the drug supply. Harm reduction strategies are especially relevant in this climate, as they aim to reduce drug-related harms independently of whether an individual chooses to enter treatment or abstain from opioid use. Assessment of harm reduction
-
Vaccines as Immunotherapies for Substance Use Disorders Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-06 Thomas R. Kosten
Substance use disorders (SUD) present a worldwide challenge with few effective therapies except for the relative efficacy of opioid pharmacotherapies, despite limited treatment access. However, the proliferation of illicit fentanyl use initiated a dramatic and cascading epidemic of lethal overdoses. This rise in fentanyl overdoses regenerated an interest in vaccine immunotherapy, which, despite an
-
Pharmacogenomic Clinical Support Tools for the Treatment of Depression Am. J. Psychiatry (IF 15.1) Pub Date : 2024-04-30 Matthew L. Baum, Alik S. Widge, Linda L. Carpenter, William M. McDonald, Bruce M. Cohen, Charles B. Nemeroff, On behalf of the American Psychiatric Association (APA) Workgroup on Biomarkers and Novel Treatments
Objective: In this review, the authors update the 2018 position statement of the American Psychiatric Association Council of Research Workgroup on Biomarkers and Novel Treatments on pharmacogenomic (PGx) tools for treatment selection in depression. Methods: The literature was reviewed for new clinical trials and meta-analyses, published from 2017 to 2022, of studies using PGx tools for treatment selection
-
The Developmental Trajectory to Cannabis Use Disorder. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-01 Jesse D Hinckley,Jacqueline-Marie N Ferland,Yasmin L Hurd
-
Progress and Challenges in Medicaid-Financed Care of Substance Use Disorder. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-01 Keith Humphreys,Christina Andrews,Richard G Frank
-
Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-01 Arthur Robin Williams,Christine M Mauro,Ben Huber,Lisa Chiodo,Stephen Crystal,Hillary Samples,Mark Olfson
-
Substance Use Disorders: Confronting Addiction From Prevention to Recovery. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-01 Kathleen T Brady,Ned H Kalin
-
Drugs and Addiction Science: NIDA Celebrates 50 Years of Research and Looks to the Future. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-05-01 Nora D Volkow
-
Association of Lower Rostral Anterior Cingulate GABA+ and Dysregulated Cortisol Stress Response With Altered Functional Connectivity in Young Adults With Lifetime Depression: A Multimodal Imaging Investigation of Trait and State Effects Am. J. Psychiatry (IF 15.1) Pub Date : 2024-04-30 Maria Ironside, Jessica M. Duda, Amelia D. Moser, Laura M. Holsen, Chun S. Zuo, Fei Du, Sarah Perlo, Christine E. Richards, Xi Chen, Lisa D. Nickerson, Kaylee E. Null, Shiba M. Esfand, Madeline M. Alexander, David J. Crowley, Meghan Lauze, Madhusmita Misra, Jill M. Goldstein, Diego A. Pizzagalli
Objective: Preclinical work suggests that excess glucocorticoids and reduced cortical γ-aminobutyric acid (GABA) may affect sex-dependent differences in brain regions implicated in stress regulation and depressive phenotypes. The authors sought to address a critical gap in knowledge, namely, how stress circuitry is functionally affected by glucocorticoids and GABA in current or remitted major depressive
-
Shared and Specific Neural Correlates of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Meta-Analysis of 243 Task-Based Functional MRI Studies Am. J. Psychiatry (IF 15.1) Pub Date : 2024-04-30 Hiroki Tamon, Junya Fujino, Takashi Itahashi, Lennart Frahm, Valeria Parlatini, Yuta Y. Aoki, Francisco Xavier Castellanos, Simon B. Eickhoff, Samuele Cortese
Objective: To investigate shared and specific neural correlates of cognitive functions in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), the authors performed a comprehensive meta-analysis and considered a balanced set of neuropsychological tasks across the two disorders. Methods: A broad set of electronic databases was searched up to December 4, 2022, for task-based
-
The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-04-01 Paul J Frick